Taysha Gene Therapies grants new hire 144,000 RSUs, 92,400 stock options priced at $5.78
TSHA•New hire equity awards under inducement plan
Taysha Gene Therapies granted a new employee 144,000 RSUs plus stock options for 92,400 shares under its 2023 Inducement Plan.
RSUs vest in four equal annual installments starting on the first anniversary, subject to continued service.
The options carry a $5.78 exercise price and a 10-year term. They vest over four years, with 25% vesting after one year and the remaining 75% vesting in equal monthly installments over the next 36 months, subject to continued service.
